Predictors and outcomes of scleroderma renal crisis: The High-Dose Versus Low-Dose D-Penicillamine in early diffuse systemic sclerosis trial

Paul J. DeMarco, Michael H. Weisman, James R. Seibold, Daniel E. Furst, Weng Kee Wong, Eric L. Hurwitz, Maureen Mayes, Barbara White, Fredrick Wigley, Walter Barr, Larry Moreland, Thomas A. Medsger, Virginia Steen, Richard W. Martin, David Collier, Arthur Weinstein, Edward Lally, John Varga, Steven R. Weiner, Brian AndrewsMicha Abeles, Philip J. Clements*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

175 Scopus citations

Fingerprint

Dive into the research topics of 'Predictors and outcomes of scleroderma renal crisis: The High-Dose Versus Low-Dose D-Penicillamine in early diffuse systemic sclerosis trial'. Together they form a unique fingerprint.

Medicine and Dentistry

INIS

Biochemistry, Genetics and Molecular Biology